1-12 of 12
Larry W. Kwak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Medicine's Coming of Age: One Drug, One Patient

Muzaffar H. Qazilbash, Larry W. Kwak
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (23): 4703–4705.
https://doi.org/10.1158/1078-0432.CCR-23-2194
Published: 01 December 2023
View article titled, Personalized Medicine's Coming of Age: One Drug, One Patient
Open the PDF for Personalized Medicine's Coming of Age: One Drug, One Patient in another window
Journal Articles

Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP

Joo Y. Song, Anamarija M. Perry, Alex F. Herrera, Lu Chen, Pamela Skrabek, Michel R. Nasr, Rebecca A. Ottesen, Janet Nikowitz, Victoria Bedell, Joyce Murata-Collins, Yuping Li, Christine McCarthy, Raju Pillai, Jinhui Wang, Xiwei Wu, Jasmine Zain, Leslie Popplewell, Larry W. Kwak, Auayporn P. Nademanee, Joyce C. Niland, David W. Scott, Qiang Gong, Wing C. Chan, Dennis D. Weisenburger
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6): 1671–1680.
https://doi.org/10.1158/1078-0432.CCR-20-2378
Published: 15 March 2021
View article titled, Double-hit Signature with <em>TP53</em> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP
Open the PDF for Double-hit Signature with <em>TP53</em> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP in another window
Includes: Supplementary data
Journal Articles

Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Robert Chen, Alex F. Herrera, Jessie Hou, Lu Chen, Jun Wu, Yuming Guo, Timothy W. Synold, Vu N. Ngo, Sandrine Puverel, Matthew Mei, Leslie Popplewell, Shuhua Yi, Joo Y. Song, Shu Tao, Xiwei Wu, Wing C. Chan, Stephen J. Forman, Larry W. Kwak, Steven T. Rosen, Edward M. Newman
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 1034–1044.
https://doi.org/10.1158/1078-0432.CCR-19-1768
Published: 02 March 2020
View article titled, Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
Open the PDF for Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo

Hong Qin, Guowei Wei, Ippei Sakamaki, Zhenyuan Dong, Wesley A. Cheng, D. Lynne Smith, Feng Wen, Han Sun, Kunhwa Kim, Soungchul Cha, Laura Bover, Sattva S. Neelapu, Larry W. Kwak
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (5): 1114–1123.
https://doi.org/10.1158/1078-0432.CCR-17-1193
Published: 28 February 2018
View article titled, Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies <em>In Vivo</em>
Open the PDF for Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma

Yasuhiro Oki, Daniela Buglio, Michelle Fanale, Luis Fayad, Amanda Copeland, Jorge Romaguera, Larry W. Kwak, Barbara Pro, Silvana de Castro Faria, Sattva Neelapu, Nathan Fowler, Fredrick Hagemeister, Jiexin Zhang, Shouhao Zhou, Lei Feng, Anas Younes
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (24): 6882–6890.
https://doi.org/10.1158/1078-0432.CCR-13-1906
Published: 16 December 2013
View article titled, Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma
Open the PDF for Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma in another window
Journal Articles

Targeting Human B-cell Malignancies through Ig Light Chain–Specific Cytotoxic T Lymphocytes

Jinsheng Weng, Soung-Chul Cha, Satoko Matsueda, Gheath Alatrash, Michael S. Popescu, Qing Yi, Jeffrey J. Molldrem, Michael Wang, Sattva S. Neelapu, Larry W. Kwak
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (18): 5945–5952.
https://doi.org/10.1158/1078-0432.CCR-11-0970
Published: 14 September 2011
View article titled, Targeting Human B-cell Malignancies through Ig Light Chain–Specific Cytotoxic T Lymphocytes
Open the PDF for Targeting Human B-cell Malignancies through Ig Light Chain–Specific Cytotoxic T Lymphocytes in another window
Journal Articles

Human-Like Mouse Models for Testing the Efficacy and Safety of Anti-β2-Microglobulin Monoclonal Antibodies to Treat Myeloma

Jing Yang, Yabing Cao, Sungyongl Hong, Haiyan Li, Jianfei Qian, Larry W. Kwak, Qing Yi
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 951–959.
https://doi.org/10.1158/1078-0432.CCR-08-1823
Published: 02 February 2009
View article titled, Human-Like Mouse Models for Testing the Efficacy and Safety of Anti-β<sub>2</sub>-Microglobulin Monoclonal Antibodies to Treat Myeloma
Open the PDF for Human-Like Mouse Models for Testing the Efficacy and Safety of Anti-β<sub>2</sub>-Microglobulin Monoclonal Antibodies to Treat Myeloma in another window
Journal Articles

A Severe Combined Immunodeficient–hu In vivo Mouse Model of Human Primary Mantle Cell Lymphoma

Michael Wang, Liang Zhang, Xiaohong Han, Jing Yang, Jianfei Qian, Sungyoul Hong, Pei Lin, Yuankai Shi, Jorge Romaguera, Larry W. Kwak, Qing Yi
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (7): 2154–2160.
https://doi.org/10.1158/1078-0432.CCR-07-4409
Published: 01 April 2008
View article titled, A Severe Combined Immunodeficient–hu <em>In vivo</em> Mouse Model of Human Primary Mantle Cell Lymphoma
Open the PDF for A Severe Combined Immunodeficient–hu <em>In vivo</em> Mouse Model of Human Primary Mantle Cell Lymphoma in another window
Journal Articles

Monocyte-Derived Dendritic Cells: A Promising Armament for Immunotherapy in Human Malignancies

Qing Yi, Larry W. Kwak
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 966–967.
https://doi.org/10.1158/1078-0432.966.11.3
Published: 11 February 2005
View article titled, Monocyte-Derived Dendritic Cells: A Promising Armament for Immunotherapy in Human Malignancies
Open the PDF for Monocyte-Derived Dendritic Cells: A Promising Armament for Immunotherapy in Human Malignancies in another window
Journal Articles

Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen

Sattva S. Neelapu, Sivasubramanian Baskar, Barry L. Gause, Carol B. Kobrin, Thelma M. Watson, Andrea Robin Frye, Robin Pennington, Linda Harvey, Elaine S. Jaffe, Richard J. Robb, Mircea C. Popescu, Larry W. Kwak
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8309–8317.
https://doi.org/10.1158/1078-0432.CCR-04-1071
Published: 28 December 2004
View article titled, Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen
Open the PDF for Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen in another window
Journal Articles

Autoreactive, Cytotoxic T Lymphocytes Specific for Peptides Derived from Normal B-Cell Differentiation Antigens in Healthy Individuals and Patients with B-Cell Malignancies

Matthias Grube, Katayoun Rezvani, Adrian Wiestner, Hiroshi Fujiwara, Giuseppe Sconocchia, Jan J. Melenhorst, Nancy Hensel, Gerald E. Marti, Larry W. Kwak, Wyndham Wilson, John A. Barrett
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 1047–1056.
https://doi.org/10.1158/1078-0432.CCR-03-0075
Published: 10 February 2004
View article titled, Autoreactive, Cytotoxic T Lymphocytes Specific for Peptides Derived from Normal B-Cell Differentiation Antigens in Healthy Individuals and Patients with B-Cell Malignancies
Open the PDF for Autoreactive, Cytotoxic T Lymphocytes Specific for Peptides Derived from Normal B-Cell Differentiation Antigens in Healthy Individuals and Patients with B-Cell Malignancies in another window
Journal Articles

Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma

Michael S. Kopreski, Floyd A. Benko, Larry W. Kwak, Christopher D. Gocke
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 1961–1965.
Published: 01 August 1999
View article titled, Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma
Open the PDF for Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma in another window